Skip to main content
. 2009 Jul 8;2009(3):CD006529. doi: 10.1002/14651858.CD006529.pub2

Endo 1995.

Methods 4 week randomised double blind study
Participants Diagnosis: In‐ and Out‐patients with DSM‐III‐R major depressive episode
Male and Female.
Threshold of baseline severity: Not reported.
 Total number of all allocated participants: N=179
 Age: range 20‐65y
Interventions Milnacipran 50‐150mg (mean: 68.6mg): N=84
 Mianserine 30‐ 60mg : N=95
Flexible dosing schedule.
Outcomes Hamilton Depression Rating Scale‐21 item, CGI‐I, CPRG
Notes Funding: by industry
Article in Japanese.
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Low risk Quote: "randomised". Probably done.
Allocation concealment (selection bias) Low risk Central allocation used.
Blinding (performance bias and detection bias) 
 All outcomes Low risk Quote: "double‐blind"
Incomplete outcome data (attrition bias) 
 All outcomes Low risk No missing primary outcome data.
Selective reporting (reporting bias) Low risk The study protocol is not available but it is clear that the published reports include all expected outcomes, including those that were pre‐specified.
Other bias Unclear risk Insufficient information to assess whether an important risk of bias exists.